By Ellen Bardash | October 2, 2024
U.S. District Judge Andrew L. Carter Jr.'s opinion ends nearly three years of stock-price drop litigation which shareholders filed after Peloton's 2021 announcement that its demand growth had slowed more than previously projected. Latham & Watkins represented Peloton in the case.
By Mason Lawlor | September 26, 2024
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in federal and state courts.
By Riley Brennan | September 25, 2024
Relying on recent U.S. Court of Appeals for the Eighth Circuit precedent, a federal judge in Missouri is allowing an employee's religious discrimination…
By Marianna Wharry | September 18, 2024
"Here, the plaintiff has alleged that a core principle of being 'Pagan' is submitting to natural forces and refusing artificial medical aid," U.S. Chief Judge F. Dennis Saylor IV wrote. "She has asserted that the mRNA technology used to develop some of the COVID-19 vaccines makes them unnatural and impermissible, as distinct from the virus-derived annual flu vaccine. That asserted connection is sufficient to support a plausible claim that accepting at least some of the COVID-19 vaccines would violate a tenet of her idiosyncratic religion."
By Colleen Murphy | September 16, 2024
"Plaintiffs assert that lenzilumab's prospects of success were overstated, that defendants failed to disclose material adverse nonpublic information concerning the scientific merits of repurposing lenzilumab as a COVID treatment as part of a scheme to mislead investors into purchasing shares of Humanigen stock," U.S. District Judge William J. Martini said.
By James Palmer | September 5, 2024
"Kristin helped pour the foundation the entire ride-share industry rests upon," CEO David Risher said.
By Riley Brennan | August 29, 2024
A federal judge in Illinois dismissed a college student's request for a partial refund after a European study abroad program was cut short because…
By Riley Brennan | August 21, 2024
Upon obtaining approval from the Food and Drug Administration, the plaintiffs claim the defendants "unilaterally cancelled plaintiffs' manufacturing and distribution rights, and unfairly demanded that plaintiffs agree to new, less favorable terms, or else defendants would choose a new manufacturer and cut plaintiffs out entirely. When plaintiffs refused to capitulate to defendants' deceptive scheme, defendants made good on their threats by deserting the deal and ignoring plaintiffs' demands for just compensation," according to the complaint.
The Legal Intelligencer | News
By Amanda O'Brien | August 13, 2024
Are personal injury firms, inherently reliant on a functioning court and jury trial system to bring in revenue, entitled to relief from the pandemic?
By Cheryl Miller | August 8, 2024
The high court raised doubts about the reach of the illusory coverage doctrine and said it didn't protect a San Francisco eatery forced to close during the pandemic.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Description:NFSA has a great opportunity for a Labor Relations Associate and Junior Counsel. This position will support NFSA's collective ba...
McCarter & English, LLP is seeking litigation attorneys for our Newark, NJ offices. Candidates must have 3-6 years of law firm experien...
McCarter & English, LLP is actively seeking a corporate associate for its office located in Boston, MA. Candidate must have 2 - 5 years ...